CP and COVID-19: Significantly higher SARS-CoV-2 RBD antibodies and functionally neutralizing antibodies in male than in female COVID-19 CP donors with mild to moderate disease in the first 30 to 114 days post-symptom onset have been previously reported (23, –, 28).